Atypical neurofibromatous neoplasms of uncertain biologic potential (ANNUBP)

Last revised by Ali Alsmair on 16 Mar 2022

Atypical neurofibromas and atypical neurofibromatous neoplasms of uncertain biologic potential (collectively AN/ANNUBP) refer to neurofibromas with atypical histological features. They are considered premalignant with an increased risk of progressing to a malignant peripheral nerve sheath tumor.

Atypical neurofibroma should be used to denote atypical histological features that do not meet the criteria for a malignant peripheral nerve sheath tumor in the setting of sporadic neurofibromas 1.  

In contrast, the term ANNUBP should be used when atypical changes are encountered in the context of neurofibromatosis type 1 (NF1) 1

To make a diagnosis of AN/ANNUBP at least two of the following features need to be identified on histology and immunohistochemistry:

  • hypercellularity
  • cytological atypia
  • loss of normal neurofibroma architecture
  • increased mitotic count > 1 mitosis/50 HPF but less than < 3 mitoses/10 HPF of 0.51 mm in diameter and 0.2 mm2 in area)

Neurofibromas are considered WHO grade 1 tumors in the WHO classification of CNS tumors 1 whereas malignant peripheral nerve sheath tumors (MPNST) are designated as low-grade or high-grade in the WHO classification of soft tissue and bone tumors 2

Presumably, due to the uncertainty of the biological behavior of AN/ANNUBP and the inconsistency in the grading nomenclature of neurofibromas and MPNST, they are not given a grade 1

The imaging characteristics of AN/ANNUBP are intermediate sharing similarities with both localized intraneural neurofibromas and malignant peripheral nerve sheath tumors, and are therefore not repeated here. 

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.